Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000731774 | SCV000859624 | uncertain significance | not provided | 2018-02-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002061005 | SCV002396213 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2022-08-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003303216 | SCV003999981 | likely benign | Cardiovascular phenotype | 2023-04-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |